Author

Jennifer Almond

Observed names: Almond J, J Almond, J. Almond

Institution: Merck Serono Ltd. (United Kingdom)

Observed institutions: University of Bern, University of Liverpool, Queen Elizabeth Hospital Birmingham, Merck Serono Ltd. (United Kingdom), University of Birmingham

OpenAlex ID: A5027567994

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

2001 · JP Neoptolemos, JA Dunn, et al. · The Lancet · 1,111

Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial

2001 · John P. Neoptolemos, Deborah D. Stocken, et al. · Annals of Surgery · 630

Cluster randomised controlled trial of expert system based on the transtheoretical ("stages of change") model for smoking prevention and cessation in schools

1999 · P. Aveyard, K K Cheng, et al. · BMJ · 155

European Study Group for Pancreatic Cancer-1 interim results: a European randomized study to assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer

2001 · J P Neoptolemos, J A Dunn, et al. · British journal of surgery · 5

The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer

2007 · J Almond, S Ralston · British Journal of Cancer · 4

ESPAC-1: A European, randomised study to assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer

2001 · J.P. Neoptolemos, D.D. Moffitt, et al. · European Journal of Cancer · 4

Survival and quality of life (QoL) of patients in ESPAC-1: A european, randomised study of assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer

2001 · J.P. Neoptolemos, D.D. Moffitt, et al. · Gastroenterology · 2

European Adjuvant Trials

2006 · Paula Ghaneh, David Smith, et al. · Springer eBooks · 1

Pcn2 Retrospective Chart Review Ofthe Management of Hand-foot Syndrome in the Treatment of Colorectal Cancer

2007 · SJ Ralston, J Almond, et al. · Value in Health

Pcn30 the Economic Benefits Oftegafurwith Uracil (uftoral) in First- Line Metastatic Colorectal Cancer

2007 · SJ Ralston, J Almond · Value in Health

Works count: 11

Citation count: 1,911

H-index: 4

I10-index: 3